Sherlock Biosciences licenses Wyss Institute's ambient

The method, integrated with highly specific CRISPR-based nucleic acid detection technology, could enable simple-to-use, portable and ultra-sensitive...

Related Keywords

Boston University ,Massachusetts ,United States ,University Of Massachusetts Medical School ,Massachusetts Institute Of Technology ,Harvard University ,Boston ,Tufts University ,Berlin ,Germany ,Spaulding Rehabilitation Hospital ,Amy Lyons ,Bryan Dechairo ,Sherlock Biosciences ,Collin Wyss ,James Collins ,Donald Ingber ,Benjamin Boettner ,Broad Institute ,Beth Israel Deaconess Medical Center ,Sherlock Biosciences Inc ,Wyss Institute ,Harvard Office Of Technology Development ,Harvard Johna Paulson School Of Engineering ,Farber Cancer Institute ,Arts Sciences ,Harvard University Office Of Technology Development ,Corporate Communications ,Sciences Engineering Accelerator ,Biologically Inspired Engineering ,Technology Development ,Founding Core Faculty ,Massachusetts Institute ,Termeer Professor ,Medical Engineering ,Wyss Founding Director ,Judah Folkman Professor ,Vascular Biology ,Harvard Medical School ,Boston Children ,Wyss Professor ,Bioinspired Engineering ,Harvard John ,Massachusetts General Hospital ,Massachusetts Medical School ,Blavatnik Biomedical Accelerator ,Physical Sciences ,Wyss Institute At Harvard University ,